The pathological features of alloxan diabetes in beagle dogs

Journal of Toxicologic Pathology

Volumn 17, Issue 3, 2004, Pages 187-195

  Watanabe, Dai ^a,b   Nakara, Hiromi ^a   Yamaguchi, Yuko ^a   Akagi, Keisuke ^a   Hoshiya, Toru ^a   Nagashima, Yoshikazu ^a   Okaniwa, Azusa ^a   Yoshikawa, Hiroyasu ^b  

^a BoZo Research Center Inc   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Alloxan; Animal model; Beagle dogs; Blood chemistry; Diabetes mellitus

Indexed keywords

EID: 23044450134     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.17.187     Document Type: Article

References (16)

1. Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970; 22: 485-518.
2. Fischer LJ. Toxicity to the insulin-secreting beta cell. In: Comprehensive Toxicology, Boekleheide K, Chapin RE, Hoyer PB, and Harris C (eds), Amsterdam: Elsevier Science, Vol 10, 701-724, 1997.
3. Black HE, Rosenblum IY, and Capen CC. Chemically induced (Streptozotocin-Alloxan) diabetes mellitus in the dog: biochemical and ultrastructural studies. Am J Pathol 1980; 98: 295-305.
4. Engerman R, Bloodworth JMB Jr, and Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 1977; 26: 760-769.
5. Duncan JR, Prasse KW, and Mahaffey EA. Proteins, lipid, and carbohydrates. Urinary system. In: Veterinary Laboratory Medicine, clinical pathology, 3rd ed., Iowa: Iowa Sate Univ. Press, 162-183, 1994.
6. Watanabe D, Nakara H, Akagi K, Ishii T, Mizuguchi H, Nagashima Y, and Okaniwa A. Oral glucose tolerance test and determination of serum fructosamine level in beagle dogs. J Toxicol Sci 2004; 29: 33-36.
7. Engerman RN and Kramer JW. Dogs with induced or spontaneous diabetes as models for the study of human diabetes mellitus. Diabetes 1982; 31 (Suppl 1): 26-29.
8. Goldner MG and Gomori G. Alloxan diabetes in the dog. Endocrinology 1943; 33: 297-308.
9. Nelson RW. Disorders of the endocrine pancreas. In: Small animal internal medicine, Nelson RW and Couto CG (eds), Missouri: Mosby, 729-777, 2003.
10. Reush CE, Liehs MR, Hoyer M, and Vochezer R. Fructosamine: a new parameter for diagnosis and metabolic control in diabetic dogs and cats. J Vet Int Med 1993; 7: 177-182.
11. Duncan JR, Prasse KW, and Mahaffey EA. Proteins, lipid, and carbohydrates. Urinary system. In: Veterinary Laboratory Medicine, clinical pathology, 3rd ed., Iowa: Iowa Sate Univ. Press, 112-129, 1994.
12. Meyer DJ and Harvey JW. Evaluation of hepatobiliary system and skeletal muscle and lipid disorders. In: Veterinary Laboratory Medicine, Interpretation & Diagnosis, 2nd ed., Penn: WB Saunders, 157-186, 1998.
13. Stockham SL and Scott MA. Hyperglycemia. In: Fundamentals of Veterinary Clinical Pathology, Iowa: Iowa State Press, 487-506, 2002.
14. Sacks DB. Diabetes mellitus. In: Tietz Textbook of Clinical Chemistry, 3rd ed., Burtis CA and Aschwood ER (eds), Philadelphia: WB Saunders, 766-772, 1999.
15. Tischler SA. The effect of the estrous cycle on diabetes mellitus in the dog. J Amer Anim Hosp Assoc 1974; 10: 122-125.
16. Gelatt KN. The canine lens. In: Veterinary Ophthalmology, 2nd ed., Gelatt KN (ed), Philadelphia and London: Lea & Febiger, 429-460, 1991.